Literature DB >> 24116964

Clinical aspects of medication overuse headaches.

Arnaldo Neves Da Silva1, Alvin E Lake.   

Abstract

Medication overuse headache (MOH) is a subset of chronic daily headache, occurring from overuse of 1 or more classes of migraine abortive medication. Acetaminophen, combination analgesics (caffeine combinations), opioids, barbiturates (butalbital), non-steroidal anti-inflammatory drugs, and triptans are the main classes of drugs implicated in the genesis of MOH. Migraine seems to be the most common diagnosis leading to MOH. The development of MOH is associated with both frequency of use of medication and behavioral predispositions. MOH is not a unitary concept. The distinction between simple (type 1) vs complex (type 2) forms is based on both the class of overused medication and behavioral factors, including psychopathology and psychological drug dependence. MOH is a challenging disorder causing decline in the quality of life and causing physical symptoms, such as daily and incapacitating headaches, insomnia, and non-restorative sleep, as well as psychological distress and reduced functioning. MOH is associated with biochemical, structural, and functional brain changes. Relapse after detoxification is a challenge, but can be addressed if the patient is followed over a prolonged period of time with a combination of prophylactic pharmacotherapy, use of abortive medication with minimal risk of MOH, withholding previously overused medication, and providing psychological (cognitive-behavioral) therapy.
© 2013 American Headache Society.

Entities:  

Keywords:  analgesic; chronic daily headache; medication overuse headache

Mesh:

Substances:

Year:  2013        PMID: 24116964     DOI: 10.1111/head.12223

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  11 in total

Review 1.  Medication overuse headache.

Authors:  Valerie Cheung; Farnaz Amoozegar; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse.

Authors:  Maria Lurenda Westergaard; Ebba Holme Hansen; Charlotte Glümer; Rigmor Højland Jensen
Journal:  Eur J Clin Pharmacol       Date:  2015-05-14       Impact factor: 2.953

3.  Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients.

Authors:  Abouch V Krymchantowski; Stewart J Tepper; Carla Jevoux; Marcelo M Valença
Journal:  Brain Sci       Date:  2016-08-15

4.  Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.

Authors:  Stephen D Silberstein; Joshua M Cohen; Ronghua Yang; Sanjay K Gandhi; Evelyn Du; Adelene E Jann; Michael J Marmura
Journal:  J Headache Pain       Date:  2021-01-07       Impact factor: 7.277

Review 5.  Applying a biopsychosocial model to migraine: rationale and clinical implications.

Authors:  Chiara Rosignoli; Raffaele Ornello; Agnese Onofri; Valeria Caponnetto; Licia Grazzi; Alberto Raggi; Matilde Leonardi; Simona Sacco
Journal:  J Headache Pain       Date:  2022-08-11       Impact factor: 8.588

6.  Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China.

Authors:  Zhihui Yan; Yuan Chen; Chunfu Chen; Congcong Li; Xiaojun Diao
Journal:  BMC Neurol       Date:  2015-09-17       Impact factor: 2.474

7.  Health and quality of life in patients with medication overuse headache syndrome after standardized inpatient rehabilitation: A cross-sectional pilot study.

Authors:  Thomas Benz; Achim Nüssle; Susanne Lehmann; Andreas R Gantenbein; Peter S Sándor; Achim Elfering; André G Aeschlimann; Felix Angst
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

8.  Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse.

Authors:  Sara Bottiroli; Federica Galli; Michele Viana; Grazia Sances; Cristina Tassorelli
Journal:  Front Psychol       Date:  2018-05-14

9.  The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

Authors:  Stephen D Silberstein; Joshua M Cohen; Michael J Seminerio; Ronghua Yang; Sait Ashina; Zaza Katsarava
Journal:  J Headache Pain       Date:  2020-09-21       Impact factor: 7.277

10.  Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study.

Authors:  Masahito Katsuki; Chinami Yamagishi; Yasuhiko Matsumori; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Takashi Ikeda; Fuminori Yamagishi
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.